RecruitingNot ApplicableNCT05612672

Evaluation of GeoHAI Implementation

GeoHAI Implementation in IP Workflow


Sponsor

Ohio State University

Enrollment

25 participants

Start Date

Feb 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but have rarely been applied to the hospital setting. In this study we apply these tools to address the challenge of Hospital Acquired Infections (HAIs) by building, implementing, and evaluating a new computer application which incorporates mapping and geographic data to assist hospital epidemiologists in identifying HAI clusters and assessing transmission risk. We expect that incorporation of geographic information into the workflow of hospital epidemiologists will have a profound effect on our understanding of disease transmission and HAI risk factors in the hospital setting, radically altering the workflow and speed of response of infection preventionists and improving their ability to prevent HAIs.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Infection preventionist or physician involved in infection prevention at participating health system

Exclusion Criteria2

  • Not an infection preventionist nor a physician involved in infection prevention
  • Does not work at the participating health system

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGeoHAI

A Geographic healthcare-associated infection (HAI) visualization and assessment tool (GeoHAI) which uses spatio-temporal Bayesian models to identify clusters of National Healthcare Safety Network (NHSN)-defined hospital onset Clostridium difficile (CDI) and multidrug resistant organisms (MDRO), and predict potential high risk areas given hospital and patient risk factors.


Locations(1)

The Ohio State University

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05612672


Related Trials